{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:45:20Z","timestamp":1787013920502,"version":"build-2736575974"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,10,5]],"date-time":"2015-10-05T00:00:00Z","timestamp":1444003200000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100007391","name":"Association pour la Recherche sur le Cancer","doi-asserted-by":"publisher","award":["5195"],"award-info":[{"award-number":["5195"]}],"id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut national de la sant\u00e9 et de la recherche m\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1111\/bjd.14017","type":"journal-article","created":{"date-parts":[[2015,7,6]],"date-time":"2015-07-06T22:18:54Z","timestamp":1436221134000},"page":"1015-1023","source":"Crossref","is-referenced-by-count":14,"title":["Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group"],"prefix":"10.1093","volume":"173","author":[{"given":"C.","family":"Hurabielle","sequence":"first","affiliation":[{"name":"Dermatology Department; AP-HP; Henri Mondor Hospital; 51 Avenue du Mar\u00e9chal de Lattre de Tassigny 94000 Cr\u00e9teil France"},{"name":"Dermatology Department; AP-HP, and INSERM U976 Saint-Louis Hospital; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ingen-Housz-Oro","sequence":"additional","affiliation":[{"name":"Dermatology Department; AP-HP; Henri Mondor Hospital; 51 Avenue du Mar\u00e9chal de Lattre de Tassigny 94000 Cr\u00e9teil France"},{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ortonne","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Pathology Department; AP-HP; Henri Mondor Hospital; 51 Avenue du Mar\u00e9chal de Lattre de Tassigny 94000 Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cornillet-Lef\u00e8bvre","sequence":"additional","affiliation":[{"name":"Laboratory of Haematology; H\u00f4pital Robert Debr\u00e9; Reims France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Merah","sequence":"additional","affiliation":[{"name":"Biological Immunology and Haematology Department; AP-HP; Henri Mondor Hospital; 51 Avenue du Mar\u00e9chal de Lattre de Tassigny 94000 Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"D'Incan","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; CHU - H\u00f4pital Estaing; Clermont-Ferrand France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Joly","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; Rouen University Hospital; INSERM U905; Institute for Research and Innovation in Biomedicine (IRIB); Rouen University; Rouen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Franck","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; AP-HP; Cochin Hospital; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Est\u00e8ve","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; CHR Orl\u00e9ans; Orl\u00e9ans France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Maubec","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; AP-HP; Bichat Hospital; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Grange","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; H\u00f4pital Robert Debr\u00e9 and EA 7319; Universit\u00e9 de Reims Champagne-Ardenne; Reims France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Machet","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; CHRU de Tours; Tours, INSERM U930; Universit\u00e9 Fran\u00e7ois Rabelais de Tours; Tours France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Laroche","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; AP-HP; Avicenne Hospital; Bobigny France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Barete","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; AP-HP; Piti\u00e9 Salp\u00eatri\u00e8re; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dalac","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; CHU Dijon; Dijon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mortier","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; CHRU Lille; Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Michel","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; CHU Mulhouse; Mulhouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Quereux","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology Department; CHU Nantes; Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Saiag","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Dermatology and Oncology Department; EA 4340; University of Versailles-SQY; CHU A Par\u00e9; Boulogne-Billancourt France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ram-Wolff","sequence":"additional","affiliation":[{"name":"Dermatology Department; AP-HP, and INSERM U976 Saint-Louis Hospital; Paris France"},{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lenormand","sequence":"additional","affiliation":[{"name":"Haematology Department; Rouen University Hospital; Rouen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wechsler","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Pathology Department; AP-HP; Henri Mondor Hospital; 51 Avenue du Mar\u00e9chal de Lattre de Tassigny 94000 Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bastuji-Garin","sequence":"additional","affiliation":[{"name":"Clinical Research Centre; AP-HP; Henri Mondor Hospital; 51 Avenue du Mar\u00e9chal de Lattre de Tassigny 94000 Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bagot","sequence":"additional","affiliation":[{"name":"Dermatology Department; AP-HP, and INSERM U976 Saint-Louis Hospital; Paris France"},{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Delfau-Larue","sequence":"additional","affiliation":[{"name":"Cutaneous Lymphoma French Study Group (GFELC); Paris France"},{"name":"Biological Immunology and Haematology Department; AP-HP; Henri Mondor Hospital; 51 Avenue du Mar\u00e9chal de Lattre de Tassigny 94000 Cr\u00e9teil France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,10,5]]},"reference":[{"key":"10.1111\/bjd.14017-BIB0001|bjd14017-cit-0001","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0002|bjd14017-cit-0002","first-page":"725","article-title":"Report of the committee on staging and classification of cutaneous T-cell lymphomas","volume":"63","author":"Bunn","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/bjd.14017-BIB0003|bjd14017-cit-0003","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","article-title":"Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients","volume":"40","author":"Zackheim","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14017-BIB0004|bjd14017-cit-0004","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2000.18.15.2908","article-title":"Primary cutaneous T-cell lymphoma: review and current concepts","volume":"18","author":"Siegel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.14017-BIB0005|bjd14017-cit-0005","first-page":"46","article-title":"The management of mycosis fungoides at Stanford - standard and innovative treatment programmes","volume":"5","author":"Hoppe","year":"1991","journal-title":"Leukemia"},{"key":"10.1111\/bjd.14017-BIB0006|bjd14017-cit-0006","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0190-9622(99)70079-4","article-title":"Prognostic factor analysis in mycosis fungoides\/S\u00e9zary syndrome","volume":"40","author":"Diamandidou","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14017-BIB0007|bjd14017-cit-0007","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1182\/blood.V92.4.1150","article-title":"Transformation of mycosis fungoides\/S\u00e9zary syndrome: clinical characteristics and prognosis","volume":"92","author":"Diamandidou","year":"1998","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0008|bjd14017-cit-0008","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/archderm.1991.01680090075007","article-title":"Prognostic clinicopathologic factors in cutaneous T-cell lymphoma","volume":"127","author":"Mart\u00ed","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.14017-BIB0009|bjd14017-cit-0009","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.14017-BIB0010|bjd14017-cit-0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and S\u00e9zary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.14017-BIB0011|bjd14017-cit-0011","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1001\/archderm.1995.01690210057009","article-title":"Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and S\u00e9zary syndrome","volume":"131","author":"Bachelez","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.14017-BIB0012|bjd14017-cit-0012","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00000372-200008000-00005","article-title":"PCR-heteroduplex analysis of T-cell receptor \u03b3 gene rearrangement in paraffin-embedded skin biopsies","volume":"22","author":"Kohler","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1111\/bjd.14017-BIB0013|bjd14017-cit-0013","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2133.2005.06649.x","article-title":"T-cell receptor \u03b3 gene rearrangement by multiplex polymerase chain reaction\/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides\/S\u00e9zary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings","volume":"153","author":"Ponti","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14017-BIB0014|bjd14017-cit-0014","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1365-2133.2009.09575.x","article-title":"T-cell receptor-\u03b3 gene rearrangement in cutaneous T-cell lymphoma: comparative study of polymerase chain reaction with denaturing gradient gel electrophoresis and GeneScan analysis","volume":"162","author":"Goeldel","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14017-BIB0015|bjd14017-cit-0015","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1182\/blood.V92.9.3376","article-title":"Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides","volume":"92","author":"Delfau-Larue","year":"1998","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0016|bjd14017-cit-0016","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1182\/blood-2009-06-230250","article-title":"Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study","volume":"115","author":"Pott","year":"2009","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0017|bjd14017-cit-0017","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1182\/blood-2014-04-568758","article-title":"Paving the road to MRD-guided treatment in CLL","volume":"123","author":"B\u00f6ttcher","year":"2014","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0018|bjd14017-cit-0018","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/leu.2014.219","article-title":"Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics\u2019 impact on survival","volume":"29","author":"Ferrero","year":"2015","journal-title":"Leukemia"},{"key":"10.1111\/bjd.14017-BIB0019|bjd14017-cit-0019","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2133.2003.05030.x","article-title":"Minimal residual disease in mycosis fungoides follow-up can be assessed by polymerase chain reaction","volume":"148","author":"Poszepczynska-Guigne","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14017-BIB0020|bjd14017-cit-0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1182\/blood.V86.1.305.bloodjournal861305","article-title":"Cutaneous T-cell infiltrates: analysis of T-cell receptor-\u03b3 gene rearrangement by polymerase chain reaction and denaturing gradient gel electrophoresis","volume":"86","author":"Theodorou","year":"1995","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0021|bjd14017-cit-0021","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/(SICI)1096-9896(199603)178:3<303::AID-PATH475>3.0.CO;2-I","article-title":"VJ rearrangements of the TCR-\u03b3 locus in peripheral T-cell lymphomas: analysis by polymerase chain reaction and denaturing gradient gel electrophoresis","volume":"178","author":"Theodorou","year":"1996","journal-title":"J Pathol"},{"key":"10.1111\/bjd.14017-BIB0022|bjd14017-cit-0022","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/1523-1747.ep12389114","article-title":"Detection of clonal T-cell receptor-\u03b3 gene rearrangements in early mycosis fungoides\/S\u00e9zary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR\/DGGE)","volume":"103","author":"Wood","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14017-BIB0023|bjd14017-cit-0023","first-page":"46","article-title":"Analysis of T cell receptor-\u03b3 gene rearrangements by denaturing gradient gel electrophoresis of GC-clamped polymerase chain reaction products. Correlation with tumour-specific sequences","volume":"146","author":"Greiner","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.14017-BIB0024|bjd14017-cit-0024","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1096-9896(199802)184:2<185::AID-PATH997>3.0.CO;2-9","article-title":"Value of clonality studies of cutaneous T lymphocytes in the diagnosis and follow-up of patients with mycosis fungoides","volume":"184","author":"Delfau-Larue","year":"1998","journal-title":"J Pathol"},{"key":"10.1111\/bjd.14017-BIB0025|bjd14017-cit-0025","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/978-3-642-78771-3_18","article-title":"Use of polymerase chain reaction in the detection of clones in lymphoproliferative diseases of the skin","volume":"139","author":"Staib","year":"1995","journal-title":"Recent Results Cancer Res"},{"key":"10.1111\/bjd.14017-BIB0026|bjd14017-cit-0026","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood.V83.11.3271.3271","article-title":"Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas","volume":"83","author":"Bottaro","year":"1994","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0027|bjd14017-cit-0027","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0733-8635(18)30171-2","article-title":"Molecular biology techniques for the diagnosis of cutaneous T-cell lymphoma","volume":"12","author":"Wood","year":"1994","journal-title":"Dermatol Clin"},{"key":"10.1111\/bjd.14017-BIB0028|bjd14017-cit-0028","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0733-8635(18)30184-0","article-title":"Clonal disease in early cutaneous T-cell lymphoma","volume":"12","author":"Mielke","year":"1994","journal-title":"Dermatol Clin"},{"key":"10.1111\/bjd.14017-BIB0029|bjd14017-cit-0029","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1046\/j.0022-202x.2001.01476.x","article-title":"Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas","volume":"117","author":"Beylot-Barry","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14017-BIB0030|bjd14017-cit-0030","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1182\/blood.V96.9.2987","article-title":"Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma","volume":"96","author":"Delfau-Larue","year":"2000","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0031|bjd14017-cit-0031","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jaad.2007.06.004","article-title":"T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides","volume":"57","author":"Thurber","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14017-BIB0032|bjd14017-cit-0032","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1182\/blood.V90.4.1636.1636_1636_1642","article-title":"Demonstration of frequent occurrence of clonal T cells in the peripheral blood of patients with primary cutaneous T-cell lymphoma","volume":"90","author":"Muche","year":"1997","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0033|bjd14017-cit-0033","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1046\/j.1523-1747.2000.00830.x","article-title":"Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides","volume":"114","author":"Fraser-Andrews","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14017-BIB0034|bjd14017-cit-0034","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1067\/mjd.2003.286","article-title":"Long-term implications of T-cell receptor gene rearrangement analysis by Southern blot in patients with cutaneous T-cell lymphoma","volume":"48","author":"Guitart","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14017-BIB0035|bjd14017-cit-0035","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1365-2133.2008.08761.x","article-title":"The prognosis of early mycosis fungoides is not influenced by phenotype and T-cell clonality","volume":"159","author":"Massone","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14017-BIB0036|bjd14017-cit-0036","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"Dongen","year":"2003","journal-title":"Leukemia"},{"key":"10.1111\/bjd.14017-BIB0037|bjd14017-cit-0037","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.leu.2404481","article-title":"Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies. Report of the BIOMED-2 Concerted Action BHM4 CT98-3936","volume":"21","author":"Bruggemann","year":"2006","journal-title":"Leukemia"},{"key":"10.1111\/bjd.14017-BIB0038|bjd14017-cit-0038","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"108","author":"Baccarani","year":"2006","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0039|bjd14017-cit-0039","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/pbc.20794","article-title":"Detectable minimal residual disease before allogeneic hematopoietic stem cell transplantation predicts extremely poor prognosis in children with acute lymphoblastic leukemia","volume":"48","author":"Sramkova","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1111\/bjd.14017-BIB0040|bjd14017-cit-0040","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/sj.leu.2403062","article-title":"Serial minimal residual disease (MRD) analysis as a predictor of response duration in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) during imatinib treatment","volume":"17","author":"Scheuring","year":"2003","journal-title":"Leukemia"},{"key":"10.1111\/bjd.14017-BIB0041|bjd14017-cit-0041","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1200\/JCO.2012.45.9628","article-title":"High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON\/SAKK AML 42A Study","volume":"31","author":"Terwijn","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.14017-BIB0042|bjd14017-cit-0042","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1182\/blood.V94.7.2225.419k03_2225_2229","article-title":"Therapy of molecular relapse in acute promyelocytic leukemia","volume":"94","author":"Coco","year":"1999","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0043|bjd14017-cit-0043","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood-2008-11-185132","article-title":"Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)","volume":"113","author":"Bassan","year":"2009","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0044|bjd14017-cit-0044","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2010.32.7270","article-title":"Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival","volume":"29","author":"Topp","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.14017-BIB0045|bjd14017-cit-0045","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2011-09-377713","article-title":"Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies","volume":"120","author":"G\u00f6kbuget","year":"2012","journal-title":"Blood"},{"key":"10.1111\/bjd.14017-BIB0046|bjd14017-cit-0046","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/bjh.12181","article-title":"Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role of WT1 expression","volume":"160","author":"Pozzi","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1111\/bjd.14017-BIB0047|bjd14017-cit-0047","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3324\/haematol.2011.044388","article-title":"Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapse","volume":"96","author":"Sockel","year":"2011","journal-title":"Haematologica"},{"key":"10.1111\/bjd.14017-BIB0048|bjd14017-cit-0048","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1182\/blood-2011-09-380386","article-title":"Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation","volume":"119","author":"Yan","year":"2012","journal-title":"Blood"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14017","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.14017\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:16:44Z","timestamp":1676366204000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/173\/4\/1015\/6615931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14017","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}